Skip to main content
logo
Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India flag India · Delayed Price · Currency is INR
133.81
+1.71 (1.29%)
Feb 16, 2026, 1:20 PM IST

NSE:SPARC Revenue

Sun Pharma Advanced Research Company had revenue of 84.50M INR in the quarter ending December 31, 2025, a decrease of -43.33%. This brings the company's revenue in the last twelve months to 531.36M, down -13.08% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharma Advanced Research Company had annual revenue of 717.66M, down -5.00%.

Revenue (ttm)
531.36M
Revenue Growth
-13.08%
P/S Ratio
80.68
Revenue / Employee
1.68M
Employees
316
Market Cap
42.87B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025717.66M-37.79M-5.00%
Mar 31, 2024755.45M-1.63B-68.36%
Mar 31, 20232.39B1.02B73.98%
Mar 31, 20221.37B-1.16B-45.74%
Mar 31, 20212.53B1.76B229.31%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Strides Pharma Science47.26B
Akums Drugs and Pharmaceuticals41.10B
Alivus Life Sciences25.12B
Aarti Pharmalabs18.01B
Indoco Remedies17.60B
Innova Captab14.97B
Solara Active Pharma Sciences12.55B
Cohance Lifesciences12.11B
Revenue Rankings

Sun Pharma Advanced Research Company News

More News